Results 301 to 310 of about 164,269 (359)

POS0229 SYSTEMIC AND TISSUE-SPECIFIC MOLECULAR PROFILING OF APREMILAST IN HEPATIC STEATOSIS: A POTENTIAL THERAPEUTIC FOR MASLD IN PsA

open access: hybrid
M. Ruiz-Ponce   +15 more
openalex   +1 more source

Hepatic Steatosis

Current Opinion in Clinical Nutrition & Metabolic Care, 2016
The high worldwide prevalence of nonalcoholic fatty liver disease (NAFLD) makes it a major public health issue. Amino acids offer a promising approach for its prevention, and several experimental studies highlight the nutritional importance of citrulline in this setting.
Prasanthi, Jegatheesan   +1 more
openaire   +3 more sources

Hepatitis C and steatosis

Clinics in Liver Disease, 2004
Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response ...
Anouk, Dev   +2 more
openaire   +2 more sources

Patomechanisms of hepatic steatosis

Orvosi Hetilap, 2010
Az elhízás és hozzá társuló kórállapotok, így az inzulinrezisztenciát kísérő nem alkoholos zsírmájbetegség a világ egészségügyi rendszereire jelentős terhet rónak. A betegség kialakulásának első lépése a májban történő trigliceridlerakódást kísérő elzsírosodás, amely később gyulladáshoz, illetve májzsugorhoz és májrákhoz is vezethet.
Péter, Fülöp, György, Paragh
openaire   +2 more sources

Imaging of Hepatic Steatosis

Seminars in Liver Disease, 2001
Hepatic steatosis is a common finding encountered during cross-sectional imaging examinations. This article reviews the imaging findings of hepatic steatosis as revealed by sonography, computed tomography, magnetic resonance imaging, and magnetic resonance spectroscopy.
E S, Siegelman, M A, Rosen
openaire   +2 more sources

Hypertension and hepatic steatosis

Current Hypertension Reports, 2008
Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic ...
Matthew J, Brookes   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy